User Auth Test Page

Live Attenuated Necator Americanus Larvae Vaccine Shows Promise In Phase 1 Trial

Infectious Disease Advisor (10/19, Gupta) reports research indicates that “a live attenuated human hookworm vaccine was well tolerated and elicited humoral and cellular immune responses to hookworm antigens.” The “phase 1 study conducted in Australia was...

Full Article
COVID-19 Infection Plus Vaccination May Provide Strongest Protection, Research Suggests

USA Today (10/19, Weintraub) reports “a growing body of research suggests” COVID-19 infection “plus vaccination provides the strongest protection against a wide range of variants.” One study published in Science found that “this combined protection seems...

Full Article
Like COVID-19, Aerosols May Be Greater Contributor To Tuberculosis Spread, Researchers Say

The New York Times (10/19, Mandavilli) reports researchers have “found that breathing may be a bigger contributor to the spread of tuberculosis than coughing, the signature symptom.” The Times adds that “as much as 90 percent of TB bacteria released from...

Full Article
Op-Ed: Lessons Learned From COVID-19 Can Change Trajectory Of Flu Seasons

In an op-ed for the New York Times (10/19), Virginia Tech engineering professor Linsey Marr writes, “Last winter, the flu nearly disappeared worldwide because precautions taken against Covid-19, including masks and social distancing, also worked to preven...

Full Article
Some Workers Asking For Prior COVID-19 Infection To Be Accepted Alongside Vaccination As Proof Of Immunity

The Wall Street Journal (10/19, Whelan, Subscription Publication) reports some workers who are opposed to COVID-19 vaccine mandates in the workplace are increasingly asking employers to recognize prior COVID-19 infection alongside vaccination as proof of...

Full Article
Only 15% Of Seniors Have Received COVID-19 Vaccine Booster Shot Despite Recommendation Of Health Experts, Data Find

CNN (10/19, Holcombe) reports on its website that health experts have encouraged vulnerable individuals to get the booster dose of the COVID-19 vaccine, but only about 15% of seniors have received it so far, according to data from the CDC. The FDA “recomm...

Full Article
Study Examines Effectiveness Of Antibiotic Treatment Guidelines For People In Low-, Middle-Income Countries With Neonatal Sepsis

Infectious Disease Advisor (10/19, Gupta) reports that while “the World Health Organization (WHO) recommends the use of ampicillin plus gentamicin as first-line therapy among individuals with neonatal sepsis residing in low- and middle-income countries (L...

Full Article
Company Says Oral COVID-19 Treatment Not Effective In Patients With Mild, Moderate Illness In Small Study

Reuters (10/19, Roy, Leo, Banerjee) reports “Atea Pharmaceuticals Inc’s experimental COVID-19 antiviral pill [AT-527], being developed with Roche, failed to help patients with mild and moderate COVID-19 in a small study of mostly low-risk patients.” The c...

Full Article
Ukraine Records Highest Daily COVID-19 Death Count

The New York Times (10/19, Varenikova) reports, “The Ministry of Health in Ukraine, the country with the lowest rate of coronavirus vaccination in Europe, reported on Tuesday that 538 people had died of Covid-19 in the country over the previous 24 hours,”...

Full Article
FDA Reportedly Planning To Allow “Mix And Match” Approach For COVID-19 Vaccine Booster Shots

The New York Times (10/18, A1, LaFraniere, Weiland) reports that the FDA “is planning to allow Americans to receive a different Covid-19 vaccine as a booster than the one they initially received, a move that could reduce the appeal of the Johnson & Johnso...

Full Article
Valneva COVID-19 Vaccine Offers Fewer Side Effects, Similar Protection To AstraZeneca Shot, Trial Data Indicate

Reuters (10/18, Kar-Gupta, MacLellan) reports that on Monday, Valneva “said its experimental COVID-19 vaccine [VLA2001] demonstrated efficacy ‘at least as good, if not better’ than AstraZeneca’s...shot in a late-stage trial comparing the two, with signifi...

Full Article
Phase 3 ACTT-3 Trial Reveals No Greater Benefit With Interferon Beta-1a Plus Remdesivir Versus Remdesivir Alone In Hospitalized Patients With COVID-19 Pneumonia

MedPage Today (10/18, Walker) reports, “Hospitalized patients with COVID-19 pneumonia recovered no faster when treated with interferon beta-1a and remdesivir (Veklury) as when treated with remdesivir alone, data from the phase III ACTT-3 trial found.” In...

Full Article
Risk Of Additional SARS-CoV-2 Mutations Looms Despite Decline In Infections

The Washington Post (10/18, A1, Achenbach, Guarino, Steckelberg) reports that as COVID-19 trends are declining, US officials “are hoping the worst of the pandemic is over.” However, the Post adds, “so much depends on the virus itself,” as “the possibility...

Full Article
US Sees 23% Increase In Flu Cases From 2020, Data Show

The Hill (10/18, Schnell) reports, “The U.S. has seen 23 percent more flu cases this year compared to last year’s influenza season, though flu activity is still below normal pre-pandemic years, according to data collected by the Walgreen[s] Flu Index.” Th...

Full Article
WHO: Eastern Democratic Republic Of Congo Confirms Three New Ebola Cases

Reuters (10/18, Holland, Peyton, Mahamba) reports, “Three new Ebola cases have been confirmed in eastern Democratic Republic of Congo, bringing the total to five in the last 10 days, the World Health Organization (WHO) said on Monday.” The new “cases were...

Full Article
Bacillus Cereus Bacteria May Be Causing Anthrax-Like Disease Among Metalworkers In Gulf Coast States, CDC Says

HealthDay (10/18, Foster, Mundell) reports that according to the CDC, “a common group of bacteria,” Bacillus cereus (B. Cereus), “may be causing deadly pneumonia or anthrax-like disease among metalworkers in the southern United States.” According to the r...

Full Article
Fauci Says Preventing Winter COVID-19 Surge Possible With More Vaccinations

The Washington Post (10/18, Firozi, Dupree) reports NIAID Director Dr. Anthony Fauci on Sunday “said it’s ‘within our capability to prevent’ yet another surge from hitting the country, as long as more people get vaccinated.” The Post adds, “Asked in an in...

Full Article
FDA Panel Backs Booster Dose For All J&J COVID-19 Vaccine Recipients

The New York Times (10/15, A1, LaFraniere, Weiland, Zimmer) reported that a key FDA “advisory committee voted unanimously Friday to recommend Johnson & Johnson booster shots, most likely clearing the way for all 15 million people who got the company’s one...

Full Article
Experts Advise Against Use Of Serology Tests To Determine COVID-19 Immunity

Stateline (10/15, Ollove) reported, “Talk of the need for coronavirus booster shots has prompted many Americans to seek antibody tests,” but in most cases, “getting an antibody test to determine immunity is a fool’s errand, infectious-disease doctors agre...

Full Article
Age, Sex Associated With Higher Risk For Antibiotic Failure Among Patients Hospitalized With Community-Acquired Pneumonia, Research Suggests

MedPage Today (10/15, Hamza) reported, “Two factors, age and sex, were associated with a higher risk for antibiotic failure among clinically stable patients hospitalized with community-acquired pneumonia (CAP), a secondary analysis of a randomized trial s...

Full Article

Request a Call from Customer Relations

Name *
Topic *
Phone Number *
Scheduled Date *
Scheduled Time *
Customer Id

First Name *
Last Name *
Email *
Customer ID

Live Attenuated Necator Americanus Larvae Vaccine Shows Promise In Phase 1 Trial

COVID-19 Infection Plus Vaccination May Provide Strongest Protection, Research Suggests

Like COVID-19, Aerosols May Be Greater Contributor To Tuberculosis Spread, Researchers Say

Op-Ed: Lessons Learned From COVID-19 Can Change Trajectory Of Flu Seasons

Some Workers Asking For Prior COVID-19 Infection To Be Accepted Alongside Vaccination As Proof Of Immunity

Only 15% Of Seniors Have Received COVID-19 Vaccine Booster Shot Despite Recommendation Of Health Experts, Data Find

Study Examines Effectiveness Of Antibiotic Treatment Guidelines For People In Low-, Middle-Income Countries With Neonatal Sepsis

Company Says Oral COVID-19 Treatment Not Effective In Patients With Mild, Moderate Illness In Small Study

Ukraine Records Highest Daily COVID-19 Death Count

FDA Reportedly Planning To Allow “Mix And Match” Approach For COVID-19 Vaccine Booster Shots

Valneva COVID-19 Vaccine Offers Fewer Side Effects, Similar Protection To AstraZeneca Shot, Trial Data Indicate

Phase 3 ACTT-3 Trial Reveals No Greater Benefit With Interferon Beta-1a Plus Remdesivir Versus Remdesivir Alone In Hospitalized Patients With COVID-19 Pneumonia

Risk Of Additional SARS-CoV-2 Mutations Looms Despite Decline In Infections

US Sees 23% Increase In Flu Cases From 2020, Data Show

WHO: Eastern Democratic Republic Of Congo Confirms Three New Ebola Cases

Bacillus Cereus Bacteria May Be Causing Anthrax-Like Disease Among Metalworkers In Gulf Coast States, CDC Says

Fauci Says Preventing Winter COVID-19 Surge Possible With More Vaccinations

FDA Panel Backs Booster Dose For All J&J COVID-19 Vaccine Recipients

Experts Advise Against Use Of Serology Tests To Determine COVID-19 Immunity

Age, Sex Associated With Higher Risk For Antibiotic Failure Among Patients Hospitalized With Community-Acquired Pneumonia, Research Suggests